The strongest heritable risk factor for development of PAH, independent of serotonergic drugs, is presence of a mutation in the type 2 receptor for the BMP pathway (BMPR2), present in the large majority of familial cases. Here, BMPR2 is linked to pulmonary arterial hypertension.